Previous
Previous

Evaluating “exon‐skipping” as a strategy to repair the CFTR nonsense mutation

Next
Next

An open label N of 1 study to evaluate the safety and efficacy of long-term treatment with Ivacaftor in combination with ATALUREN (PTC124) in Subjects with Nonsense Mutation Cystic Fibrosis